| Document And Entity Information | Nov. 10, 2022 |
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | Nov. 10, 2022 |
| Entity Registrant Name | Rani Therapeutics Holdings, Inc. |
| Entity Central Index Key | 0001856725 |
| Entity Emerging Growth Company | true |
| Securities Act File Number | 001-40672 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 86-3114789 |
| Entity Address, Address Line One | 2051 Ringwood Avenue |
| Entity Address, City or Town | San Jose |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 95131 |
| City Area Code | (408) |
| Local Phone Number | 457-3700 |
| Entity Information, Former Legal or Registered Name | N/A |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Entity Ex Transition Period | false |
| Title of 12(b) Security | Class A common stock, par value $0.0001 per share |
| Trading Symbol | RANI |
| Security Exchange Name | NASDAQ |
